Cover of: Biomarkers of disease | Read Online
Share

Biomarkers of disease an evidence-based approach by

  • 378 Want to read
  • ·
  • 23 Currently reading

Published by Cambridge University Press in Cambridge, New York .
Written in English

Subjects:

  • Biochemical markers -- Congresses.,
  • Clinical chemistry -- Congresses.

Book details:

Edition Notes

Statementedited by Andrew K. Trull ... [et al.]
GenreCongresses.
ContributionsTrull, Andrew K.
Classifications
LC ClassificationsR853.B54 B566 2002
The Physical Object
Paginationxxii, 494 p. :
Number of Pages494
ID Numbers
Open LibraryOL3656265M
ISBN 100521811023
LC Control Number2002510385
OCLC/WorldCa48362600

Download Biomarkers of disease

PDF EPUB FB2 MOBI RTF

This comprehensive book details the latest advances made in the field of biomarker research and development in kidney diseases. The book is an ideal companion for those interested in biomarker research and development, proteomics and metabolomics, kidney diseases, statistical analysis, transplantation, and preeclampsia.   The present book focuses on the presentation and evaluation of the most promising classical and novel biochemical markers used in CVD (coronary artery disease, hypertension, heart failure, hyperlipidemia, peripheral arterial disease).   This comprehensive book details the latest advances made in the field of biomarker research and development in kidney diseases. The book is an ideal companion for those interested in biomarker research and development, proteomics and metabolomics, kidney diseases, statistical analysis, transplantation, and : $ To aid in this imperative research, Dr. Kewal K. Jain’s Handbook of Biomarkers thoroughly describes many different types of biomarkers and their discovery using various "-omics" technologies, such as proteomics and metabolomics, along with the background information needed for the evaluation of biomarkers as well as the essential procedures for their validation and use in clinical trials. With .

Charles L. Edelstein. A biomarker is a molecule that is measured as a marker of normal biological processes, disease processes or the response to a diagnostic or therapeutic intervention. Kidney diseases like acute kidney injury, chronic kidney disease, diabetic nephropathy, glomerular disease, renal cancer and preeclampsia still have a high morbidity.   Biomarkers of Disease: An Evidence-Based Approach. Eds Andrew K Trull, Laurence M Demers, David W Holt, Atholl Johnston, J Michael Tredger, Christopher P Price. Cambridge University Press, £80, pp ISBN 0 3. Rating: ★Author: Denis O'Reilly.   This book continues the legacy of a well-established reference within the pharmaceutical industry – providing perspective, covering recent developments in technologies that have enabled the expanded use of biomarkers, and discussing biomarker characterization and validation and applications throughout drug discovery and development. The topics address numerous aspects of medicine, demonstrating the current conceptual status of biomarkers as clinical tools and as surrogate endpoints in clinical research. This book highlights the current state of biomarkers and will aid scientists and clinicians to develop better and more specific biomarkers for disease management.

  "The field of Biomarkers and Precision Medicine in drug development is rapidly evolving and this book presents a snapshot of exciting new approaches. By presenting a wide range of biomarker applications, discussed by knowledgeable and experienced scientists, readers will develop an appreciation of the scope and breadth of biomarker knowledge. Abstract. Despite advances in cardiovascular disease (CVD) risk assessment and prevention, CVD remains a leading cause of morbidity and mortality. Novel biomarkers may help to improve risk assessment for both atherosclerotic CVD and heart failure and to guide preventive therapy. This comprehensive book details the latest advances made in the field of biomarker research and development in kidney diseases. The book is an ideal companion for those interested in biomarker research and development, proteomics and metabolomics, kidney diseases, statistical analysis, transplantation and preeclampsia. Biomarkers in Liver Disease embraces a holistic approach by combining detailed information on different conditions that affect the liver and the use of biomarkers. Biomarkers are described in terms of conventional, new and emerging analytes, techniques, platforms and applications. It covers the latest knowledge, trends and innovations.